FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591991112> ?p ?o ?g. }

• W2591991112 abstract "Abstract Background Radiogenetic therapy is a novel approach in the treatment of cancer, which employs genetic modification to alter the sensitivity of tumor cells to the effect of applied radiation. Aim To select a potent radiation inducible promoter in the context of brain tumors and to investigate if CArG radio responsive motifs or other elements in the promoter nucleotide sequences can correlate to its response to radiation. Methods To select initial candidates for promoter inducible elements, the levels of mRNA expression of six different promoters were assessed using Quantitative RTPCR in D54 MG cells before and after radiation exposure. Recombinant Ad/reporter genes driven by five different promoters; CMV, VEGF, FLT‐1, DR5 and survivin were constructed. Glioma cell lines were infected with different multiplicity of infection of the (promoter) Ad or CMV Ad. Cells were then exposed to a range of radiation (0–12 Gy) at single fraction. Fluorescent microscopy, Luc assay and X‐gal staining was used to detect the level of expression of related genes. Different glioma cell lines and normal astrocytes were infected with Ad survivin and exposed to radiation. The promoters were analyzed for presence of CArG radio‐responsive motifs and CCAAT box consensus using NCBI blast bioinformatics software. Results Radiotherapy increases the expression of gene expression by 1.25–2.5 fold in different promoters other than survivin after 2 h of radiation. RNA analysis was done and has shown an increase in copy number of tenfold for survivin. Most importantly cells treated with RT and Ad Luc driven by survivin promoter showed a fivefold increase in expression after 2 Gy of radiation in comparison to non‐irradiated cells. Presence or absence of CArG motifs did not correlate with promoter response to radiation. Survivin with the best response to radiation had the lowest number of CCAAT box. Conclusion Survivin is a selective potent radiation inducible promoter for glioblastoma viral gene therapy and this response to radiation could be independent of CArG motifs." @default.
• W2591991112 created "2017-03-16" @default.
• W2591991112 creator A5003418175 @default.
• W2591991112 creator A5014060039 @default.
• W2591991112 creator A5022987623 @default.
• W2591991112 creator A5031684819 @default.
• W2591991112 creator A5052212062 @default.
• W2591991112 date "2017-03-01" @default.
• W2591991112 modified "2023-10-14" @default.
• W2591991112 title "Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs" @default.
• W2591991112 cites W1523680364 @default.
• W2591991112 cites W1581805224 @default.
• W2591991112 cites W1878450308 @default.
• W2591991112 cites W1879163071 @default.
• W2591991112 cites W1963689274 @default.
• W2591991112 cites W1964638367 @default.
• W2591991112 cites W1968930897 @default.
• W2591991112 cites W1972163180 @default.
• W2591991112 cites W1975610042 @default.
• W2591991112 cites W1976878784 @default.
• W2591991112 cites W1990842394 @default.
• W2591991112 cites W1995963878 @default.
• W2591991112 cites W1998662932 @default.
• W2591991112 cites W2002528642 @default.
• W2591991112 cites W2003438982 @default.
• W2591991112 cites W2005543839 @default.
• W2591991112 cites W2014601515 @default.
• W2591991112 cites W2017309872 @default.
• W2591991112 cites W2017813545 @default.
• W2591991112 cites W2021276173 @default.
• W2591991112 cites W2023112354 @default.
• W2591991112 cites W2024104228 @default.
• W2591991112 cites W2025568235 @default.
• W2591991112 cites W2030380228 @default.
• W2591991112 cites W2042591738 @default.
• W2591991112 cites W2045321300 @default.
• W2591991112 cites W2048456023 @default.
• W2591991112 cites W2050912993 @default.
• W2591991112 cites W2053360677 @default.
• W2591991112 cites W2056493735 @default.
• W2591991112 cites W2060551076 @default.
• W2591991112 cites W2073947345 @default.
• W2591991112 cites W2074111828 @default.
• W2591991112 cites W2077266145 @default.
• W2591991112 cites W2078817650 @default.
• W2591991112 cites W2081993627 @default.
• W2591991112 cites W2083877143 @default.
• W2591991112 cites W2085526008 @default.
• W2591991112 cites W2089806726 @default.
• W2591991112 cites W2090280626 @default.
• W2591991112 cites W2093574860 @default.
• W2591991112 cites W2105812558 @default.
• W2591991112 cites W2109274792 @default.
• W2591991112 cites W2113267995 @default.
• W2591991112 cites W2118677902 @default.
• W2591991112 cites W2121365554 @default.
• W2591991112 cites W2128923622 @default.
• W2591991112 cites W2130450923 @default.
• W2591991112 cites W2134610311 @default.
• W2591991112 cites W2143981899 @default.
• W2591991112 cites W2151442912 @default.
• W2591991112 cites W2157069447 @default.
• W2591991112 cites W2158464695 @default.
• W2591991112 cites W2165053108 @default.
• W2591991112 cites W2165114272 @default.
• W2591991112 cites W2166798417 @default.
• W2591991112 cites W2236165901 @default.
• W2591991112 cites W2314993818 @default.
• W2591991112 cites W2318035377 @default.
• W2591991112 cites W2320950410 @default.
• W2591991112 cites W2332181015 @default.
• W2591991112 cites W2505496882 @default.
• W2591991112 cites W2604251330 @default.
• W2591991112 cites W338754679 @default.
• W2591991112 cites W34479994 @default.
• W2591991112 cites W4253410149 @default.
• W2591991112 cites W64070959 @default.
• W2591991112 doi "https://doi.org/10.1186/s40169-017-0140-y" @default.
• W2591991112 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5332320" @default.
• W2591991112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28251571" @default.
• W2591991112 hasPublicationYear "2017" @default.
• W2591991112 type Work @default.
• W2591991112 sameAs 2591991112 @default.
• W2591991112 citedByCount "10" @default.
• W2591991112 countsByYear W25919911122017 @default.
• W2591991112 countsByYear W25919911122018 @default.
• W2591991112 countsByYear W25919911122019 @default.
• W2591991112 countsByYear W25919911122020 @default.
• W2591991112 countsByYear W25919911122021 @default.
• W2591991112 countsByYear W25919911122022 @default.
• W2591991112 countsByYear W25919911122023 @default.
• W2591991112 crossrefType "journal-article" @default.
• W2591991112 hasAuthorship W2591991112A5003418175 @default.
• W2591991112 hasAuthorship W2591991112A5014060039 @default.
• W2591991112 hasAuthorship W2591991112A5022987623 @default.
• W2591991112 hasAuthorship W2591991112A5031684819 @default.
• W2591991112 hasAuthorship W2591991112A5052212062 @default.
• W2591991112 hasBestOaLocation W25919911121 @default.
• W2591991112 hasConcept C101762097 @default.
• W2591991112 hasConcept C104317684 @default.

• next